ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Genetically Modified Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-1P14636
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Genetically Modified Drug Market Research Report 2023
BUY CHAPTERS

Global Genetically Modified Drug Market Research Report 2025

Code: QYRE-Auto-1P14636
Report
May 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pharming Group NV
Pfizer Inc
Roche
Abbott Laboratories
Johnson & Johnson
Merck
F.Hoffmann-La Roche
Sanofi
Novartis
Eli Lilly
Takeda
Baxter
GlaxoSmithKline PLC
LFB Biotechnologies SA
Amgen Inc

Genetically Modified Drug Market Size

The global market for Genetically Modified Drug was valued at US$ 2587 million in the year 2024 and is projected to reach a revised size of US$ 3867 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Genetically Modified Drug Market

Genetically Modified Drug Market

Drugs made by genetically modified means are also called "biological drugs"
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Genetically Modified Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetically Modified Drug.
The Genetically Modified Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genetically Modified Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetically Modified Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Genetically Modified Drug Market Report

Report Metric Details
Report Name Genetically Modified Drug Market
Accounted market size in year US$ 2587 million
Forecasted market size in 2031 US$ 3867 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company LFB Biotechnologies SA, Pharming Group NV, Pfizer, Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., Amgen, F. Hoffmann-La Roche, Sanofi, Novartis, Eli Lilly, Takeda, Baxter, GlaxoSmithKline
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Genetically Modified Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Genetically Modified Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Genetically Modified Drug Market growing?

Ans: The Genetically Modified Drug Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Genetically Modified Drug Market size in 2031?

Ans: The Genetically Modified Drug Market size in 2031 will be US$ 3867 million.

Who are the main players in the Genetically Modified Drug Market report?

Ans: The main players in the Genetically Modified Drug Market are LFB Biotechnologies SA, Pharming Group NV, Pfizer, Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., Amgen, F. Hoffmann-La Roche, Sanofi, Novartis, Eli Lilly, Takeda, Baxter, GlaxoSmithKline

What are the Application segmentation covered in the Genetically Modified Drug Market report?

Ans: The Applications covered in the Genetically Modified Drug Market report are Hospital, Clinic

What are the Type segmentation covered in the Genetically Modified Drug Market report?

Ans: The Types covered in the Genetically Modified Drug Market report are Transgenic Animal, Transgenic Plant

Recommended Reports

Genetic Drug Markets

Diagnostics & Testing

Therapies & Treatment

1 Genetically Modified Drug Market Overview
1.1 Product Definition
1.2 Genetically Modified Drug by Type
1.2.1 Global Genetically Modified Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Transgenic Animal
1.2.3 Transgenic Plant
1.3 Genetically Modified Drug by Application
1.3.1 Global Genetically Modified Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Genetically Modified Drug Market Size Estimates and Forecasts
1.4.1 Global Genetically Modified Drug Revenue 2020-2031
1.4.2 Global Genetically Modified Drug Sales 2020-2031
1.4.3 Global Genetically Modified Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Genetically Modified Drug Market Competition by Manufacturers
2.1 Global Genetically Modified Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Genetically Modified Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Genetically Modified Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Genetically Modified Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Genetically Modified Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genetically Modified Drug, Product Type & Application
2.7 Global Key Manufacturers of Genetically Modified Drug, Date of Enter into This Industry
2.8 Global Genetically Modified Drug Market Competitive Situation and Trends
2.8.1 Global Genetically Modified Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Genetically Modified Drug Players Market Share by Revenue
2.8.3 Global Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Genetically Modified Drug Market Scenario by Region
3.1 Global Genetically Modified Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Genetically Modified Drug Sales by Region: 2020-2031
3.2.1 Global Genetically Modified Drug Sales by Region: 2020-2025
3.2.2 Global Genetically Modified Drug Sales by Region: 2026-2031
3.3 Global Genetically Modified Drug Revenue by Region: 2020-2031
3.3.1 Global Genetically Modified Drug Revenue by Region: 2020-2025
3.3.2 Global Genetically Modified Drug Revenue by Region: 2026-2031
3.4 North America Genetically Modified Drug Market Facts & Figures by Country
3.4.1 North America Genetically Modified Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Genetically Modified Drug Sales by Country (2020-2031)
3.4.3 North America Genetically Modified Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Genetically Modified Drug Market Facts & Figures by Country
3.5.1 Europe Genetically Modified Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Genetically Modified Drug Sales by Country (2020-2031)
3.5.3 Europe Genetically Modified Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genetically Modified Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Genetically Modified Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Genetically Modified Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Genetically Modified Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Genetically Modified Drug Market Facts & Figures by Country
3.7.1 Latin America Genetically Modified Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Genetically Modified Drug Sales by Country (2020-2031)
3.7.3 Latin America Genetically Modified Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genetically Modified Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Genetically Modified Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Genetically Modified Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Genetically Modified Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Genetically Modified Drug Sales by Type (2020-2031)
4.1.1 Global Genetically Modified Drug Sales by Type (2020-2025)
4.1.2 Global Genetically Modified Drug Sales by Type (2026-2031)
4.1.3 Global Genetically Modified Drug Sales Market Share by Type (2020-2031)
4.2 Global Genetically Modified Drug Revenue by Type (2020-2031)
4.2.1 Global Genetically Modified Drug Revenue by Type (2020-2025)
4.2.2 Global Genetically Modified Drug Revenue by Type (2026-2031)
4.2.3 Global Genetically Modified Drug Revenue Market Share by Type (2020-2031)
4.3 Global Genetically Modified Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Genetically Modified Drug Sales by Application (2020-2031)
5.1.1 Global Genetically Modified Drug Sales by Application (2020-2025)
5.1.2 Global Genetically Modified Drug Sales by Application (2026-2031)
5.1.3 Global Genetically Modified Drug Sales Market Share by Application (2020-2031)
5.2 Global Genetically Modified Drug Revenue by Application (2020-2031)
5.2.1 Global Genetically Modified Drug Revenue by Application (2020-2025)
5.2.2 Global Genetically Modified Drug Revenue by Application (2026-2031)
5.2.3 Global Genetically Modified Drug Revenue Market Share by Application (2020-2031)
5.3 Global Genetically Modified Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 LFB Biotechnologies SA
6.1.1 LFB Biotechnologies SA Company Information
6.1.2 LFB Biotechnologies SA Description and Business Overview
6.1.3 LFB Biotechnologies SA Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 LFB Biotechnologies SA Genetically Modified Drug Product Portfolio
6.1.5 LFB Biotechnologies SA Recent Developments/Updates
6.2 Pharming Group NV
6.2.1 Pharming Group NV Company Information
6.2.2 Pharming Group NV Description and Business Overview
6.2.3 Pharming Group NV Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pharming Group NV Genetically Modified Drug Product Portfolio
6.2.5 Pharming Group NV Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Genetically Modified Drug Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Roche
6.4.1 Roche Company Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Roche Genetically Modified Drug Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Abbott Laboratories
6.5.1 Abbott Laboratories Company Information
6.5.2 Abbott Laboratories Description and Business Overview
6.5.3 Abbott Laboratories Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Abbott Laboratories Genetically Modified Drug Product Portfolio
6.5.5 Abbott Laboratories Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Johnson & Johnson Genetically Modified Drug Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Merck & Co.
6.7.1 Merck & Co. Company Information
6.7.2 Merck & Co. Description and Business Overview
6.7.3 Merck & Co. Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck & Co. Genetically Modified Drug Product Portfolio
6.7.5 Merck & Co. Recent Developments/Updates
6.8 Amgen
6.8.1 Amgen Company Information
6.8.2 Amgen Description and Business Overview
6.8.3 Amgen Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Amgen Genetically Modified Drug Product Portfolio
6.8.5 Amgen Recent Developments/Updates
6.9 F. Hoffmann-La Roche
6.9.1 F. Hoffmann-La Roche Company Information
6.9.2 F. Hoffmann-La Roche Description and Business Overview
6.9.3 F. Hoffmann-La Roche Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 F. Hoffmann-La Roche Genetically Modified Drug Product Portfolio
6.9.5 F. Hoffmann-La Roche Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Company Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sanofi Genetically Modified Drug Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Company Information
6.11.2 Novartis Description and Business Overview
6.11.3 Novartis Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Novartis Genetically Modified Drug Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 Eli Lilly
6.12.1 Eli Lilly Company Information
6.12.2 Eli Lilly Description and Business Overview
6.12.3 Eli Lilly Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Eli Lilly Genetically Modified Drug Product Portfolio
6.12.5 Eli Lilly Recent Developments/Updates
6.13 Takeda
6.13.1 Takeda Company Information
6.13.2 Takeda Description and Business Overview
6.13.3 Takeda Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Takeda Genetically Modified Drug Product Portfolio
6.13.5 Takeda Recent Developments/Updates
6.14 Baxter
6.14.1 Baxter Company Information
6.14.2 Baxter Description and Business Overview
6.14.3 Baxter Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Baxter Genetically Modified Drug Product Portfolio
6.14.5 Baxter Recent Developments/Updates
6.15 GlaxoSmithKline
6.15.1 GlaxoSmithKline Company Information
6.15.2 GlaxoSmithKline Description and Business Overview
6.15.3 GlaxoSmithKline Genetically Modified Drug Sales, Revenue and Gross Margin (2020-2025)
6.15.4 GlaxoSmithKline Genetically Modified Drug Product Portfolio
6.15.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genetically Modified Drug Industry Chain Analysis
7.2 Genetically Modified Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genetically Modified Drug Production Mode & Process Analysis
7.4 Genetically Modified Drug Sales and Marketing
7.4.1 Genetically Modified Drug Sales Channels
7.4.2 Genetically Modified Drug Distributors
7.5 Genetically Modified Drug Customer Analysis
8 Genetically Modified Drug Market Dynamics
8.1 Genetically Modified Drug Industry Trends
8.2 Genetically Modified Drug Market Drivers
8.3 Genetically Modified Drug Market Challenges
8.4 Genetically Modified Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pharming Group NV
Pfizer Inc
Roche
Abbott Laboratories
Johnson & Johnson
Merck
F.Hoffmann-La Roche
Sanofi
Novartis
Eli Lilly
Takeda
Baxter
GlaxoSmithKline PLC
LFB Biotechnologies SA
Amgen Inc
List of Tables
 Table 1. Global Genetically Modified Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Genetically Modified Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Genetically Modified Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Genetically Modified Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Genetically Modified Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Genetically Modified Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Genetically Modified Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Genetically Modified Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Genetically Modified Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Genetically Modified Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Genetically Modified Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Genetically Modified Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Genetically Modified Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetically Modified Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Genetically Modified Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Genetically Modified Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Genetically Modified Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Genetically Modified Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Genetically Modified Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Genetically Modified Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Genetically Modified Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Genetically Modified Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Genetically Modified Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Genetically Modified Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Genetically Modified Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Genetically Modified Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Genetically Modified Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Genetically Modified Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Genetically Modified Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Genetically Modified Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Genetically Modified Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Genetically Modified Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Genetically Modified Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Genetically Modified Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Genetically Modified Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Genetically Modified Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Genetically Modified Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Genetically Modified Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Genetically Modified Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Genetically Modified Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Genetically Modified Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Genetically Modified Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Genetically Modified Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Genetically Modified Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Genetically Modified Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Genetically Modified Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Genetically Modified Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Genetically Modified Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Genetically Modified Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Genetically Modified Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Genetically Modified Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Genetically Modified Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Genetically Modified Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Genetically Modified Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Genetically Modified Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Genetically Modified Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Genetically Modified Drug Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Genetically Modified Drug Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Genetically Modified Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Genetically Modified Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Genetically Modified Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Genetically Modified Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Genetically Modified Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Genetically Modified Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Genetically Modified Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Genetically Modified Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Genetically Modified Drug Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Genetically Modified Drug Price (US$/Unit) by Application (2026-2031)
 Table 70. LFB Biotechnologies SA Company Information
 Table 71. LFB Biotechnologies SA Description and Business Overview
 Table 72. LFB Biotechnologies SA Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. LFB Biotechnologies SA Genetically Modified Drug Product
 Table 74. LFB Biotechnologies SA Recent Developments/Updates
 Table 75. Pharming Group NV Company Information
 Table 76. Pharming Group NV Description and Business Overview
 Table 77. Pharming Group NV Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pharming Group NV Genetically Modified Drug Product
 Table 79. Pharming Group NV Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Genetically Modified Drug Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Roche Company Information
 Table 86. Roche Description and Business Overview
 Table 87. Roche Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Roche Genetically Modified Drug Product
 Table 89. Roche Recent Developments/Updates
 Table 90. Abbott Laboratories Company Information
 Table 91. Abbott Laboratories Description and Business Overview
 Table 92. Abbott Laboratories Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Abbott Laboratories Genetically Modified Drug Product
 Table 94. Abbott Laboratories Recent Developments/Updates
 Table 95. Johnson & Johnson Company Information
 Table 96. Johnson & Johnson Description and Business Overview
 Table 97. Johnson & Johnson Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Johnson & Johnson Genetically Modified Drug Product
 Table 99. Johnson & Johnson Recent Developments/Updates
 Table 100. Merck & Co. Company Information
 Table 101. Merck & Co. Description and Business Overview
 Table 102. Merck & Co. Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Merck & Co. Genetically Modified Drug Product
 Table 104. Merck & Co. Recent Developments/Updates
 Table 105. Amgen Company Information
 Table 106. Amgen Description and Business Overview
 Table 107. Amgen Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Amgen Genetically Modified Drug Product
 Table 109. Amgen Recent Developments/Updates
 Table 110. F. Hoffmann-La Roche Company Information
 Table 111. F. Hoffmann-La Roche Description and Business Overview
 Table 112. F. Hoffmann-La Roche Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. F. Hoffmann-La Roche Genetically Modified Drug Product
 Table 114. F. Hoffmann-La Roche Recent Developments/Updates
 Table 115. Sanofi Company Information
 Table 116. Sanofi Description and Business Overview
 Table 117. Sanofi Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Sanofi Genetically Modified Drug Product
 Table 119. Sanofi Recent Developments/Updates
 Table 120. Novartis Company Information
 Table 121. Novartis Description and Business Overview
 Table 122. Novartis Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Novartis Genetically Modified Drug Product
 Table 124. Novartis Recent Developments/Updates
 Table 125. Eli Lilly Company Information
 Table 126. Eli Lilly Description and Business Overview
 Table 127. Eli Lilly Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Eli Lilly Genetically Modified Drug Product
 Table 129. Eli Lilly Recent Developments/Updates
 Table 130. Takeda Company Information
 Table 131. Takeda Description and Business Overview
 Table 132. Takeda Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Takeda Genetically Modified Drug Product
 Table 134. Takeda Recent Developments/Updates
 Table 135. Baxter Company Information
 Table 136. Baxter Description and Business Overview
 Table 137. Baxter Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Baxter Genetically Modified Drug Product
 Table 139. Baxter Recent Developments/Updates
 Table 140. GlaxoSmithKline Company Information
 Table 141. GlaxoSmithKline Description and Business Overview
 Table 142. GlaxoSmithKline Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. GlaxoSmithKline Genetically Modified Drug Product
 Table 144. GlaxoSmithKline Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Genetically Modified Drug Distributors List
 Table 148. Genetically Modified Drug Customers List
 Table 149. Genetically Modified Drug Market Trends
 Table 150. Genetically Modified Drug Market Drivers
 Table 151. Genetically Modified Drug Market Challenges
 Table 152. Genetically Modified Drug Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Genetically Modified Drug
 Figure 2. Global Genetically Modified Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Genetically Modified Drug Market Share by Type: 2024 & 2031
 Figure 4. Transgenic Animal Product Picture
 Figure 5. Transgenic Plant Product Picture
 Figure 6. Global Genetically Modified Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Genetically Modified Drug Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Genetically Modified Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Genetically Modified Drug Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Genetically Modified Drug Sales (2020-2031) & (K Units)
 Figure 13. Global Genetically Modified Drug Average Price (US$/Unit) & (2020-2031)
 Figure 14. Genetically Modified Drug Report Years Considered
 Figure 15. Genetically Modified Drug Sales Share by Manufacturers in 2024
 Figure 16. Global Genetically Modified Drug Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Genetically Modified Drug Players: Market Share by Revenue in Genetically Modified Drug in 2024
 Figure 18. Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Genetically Modified Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Genetically Modified Drug Sales Market Share by Country (2020-2031)
 Figure 21. North America Genetically Modified Drug Revenue Market Share by Country (2020-2031)
 Figure 22. United States Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Genetically Modified Drug Sales Market Share by Country (2020-2031)
 Figure 25. Europe Genetically Modified Drug Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Genetically Modified Drug Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Genetically Modified Drug Revenue Market Share by Region (2020-2031)
 Figure 33. China Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Genetically Modified Drug Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Genetically Modified Drug Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Genetically Modified Drug Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Genetically Modified Drug Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Genetically Modified Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Genetically Modified Drug by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Genetically Modified Drug by Type (2020-2031)
 Figure 52. Global Genetically Modified Drug Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Genetically Modified Drug by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Genetically Modified Drug by Application (2020-2031)
 Figure 55. Global Genetically Modified Drug Price (US$/Unit) by Application (2020-2031)
 Figure 56. Genetically Modified Drug Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Genetic Modification Market Insights Forecast to 2030
Protein Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Genetically Modified Mouse Market Research Report 2024
Global Genetically Modified Rat Market Research Report 2024
Bovine Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chemical Drug and Biologic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COPD Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biotechnology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GM Crops Market Insights Forecast to 2030
Pet Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biotech Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biotech Modified Agricultural Product Market Insights Forecast to 2030
Drugs of Bioengineered Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Beauty Injections Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Molecular Farming Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Farm Animals Medicines and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Genetically Engineered Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transfection Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Synthetic Biology Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Genetically Modified GMO Seeds Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions